कृपया अन्य खोज का प्रयास करें
SK Biopharmaceuticals Co., Ltd., a pharmaceutical company, engages in the research and development of drugs for the treatment of central nervous system disorders. The company offers Cenobamate, an anti-seizure medication, for the treatment of epilepsy and Solriamfetol medication. It also develops Carisbamate that is in Phase 3 trials to treat lennox-gastaut syndrome; and Relenopride, which is in Phase 2 clinical trials for treatment of rare neurological disease; SKL24741, which is in Phase 1 clinical trials for the treatment of epilepsy; SKL20540, which is in Phase 1 clinical trials for the treatment of schizophrenia; SKL27969 for treatment of advanced solid tumors; SKL13865 clinical trials to treat attention deficit/hyperactivity disorder; and SKL-PSY that is in Phase 1 clinical trials to treat bipolar disorder. The company was founded in 1993 and is headquartered in Seongnam-si, South Korea. SK Biopharmaceuticals Co., Ltd. is a subsidiary of SK Inc.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Dong Hoon Lee | - | 2020 | CEO, President & Executive Director |
Min-Sup Song | - | 2019 | Independent Chairman of the Board |
Hae Young Ahn | - | 2019 | Independent Outside Director |
William H. Koster | 79 | - | Member of Advisory Board |
Frank Castellana | - | - | Member of Advisory Board |
Gary J. Bennett | - | - | Member of Advisory Board |
Emilio Perucca | - | - | Member of Advisory Board |
H. Steve White | - | - | Member of Advisory Board |
Jacqueline A. French | - | 2023 | Member of Scientific Advisory Board |
Yung Jue Bang | - | 2019 | Chairman of the Scientific Advisory Board |
Min-Ji Kim | - | 2023 | Independent Director |
Cheol-Young Maeng | - | 2023 | Member of Scientific Advisory Board |
Linda R. Watkins | - | - | Member of Advisory Board |
Hiroaki Masuzaki | - | - | Member of Advisory Board |
Il Minn | - | 2023 | Member of Scientific Advisory Board |
Yeon-Tae Kim | - | 2023 | Director |
Steve S. Chung | - | 2023 | Member of Scientific Advisory Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है